Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community

por Thompson, Alan J, Moccia, Marcello, Amato, Maria Pia, Calabresi, Peter A, Finlayson, Marcia, Hawton, Annie, Lublin, Fred D, Marrie, Ruth Ann, Montalban, Xavier, Panzara, Michael, Sormani, Maria Pia, Strum, Jon, Vickrey, Barbara G, Coetzee, Timothy
Publicado 2023

Evaluating methods for Avian avulavirus-1 whole genome sequencing

por Tal, Saar, Ben Izhak, Meirav, Wachtel, Chaim, Wiseman, Anat, Braun, Tzipi, Yechezkel, Elinor, Golan, Einav, Hadas, Ruth, Turjeman, Adi, Banet-Noach, Caroline, Bronstein, Michal, Lublin, Avishai, Berman, Elyakum, Raviv, Ziv, Pirak, Michael, Klement, Eyal, Louzoun, Yoram
Publicado 2019

Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells

por O’Hara, Bethany A., Gee, Gretchen V., Haley, Sheila A., Morris-Love, Jenna, Nyblade, Charlotte, Nieves, Chris, Hanson, Barbara A., Dang, Xin, Turner, Timothy J., Chavin, Jeffrey M., Lublin, Alex, Koralnik, Igor J., Atwood, Walter J.
Publicado 2021

Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: Identification of a candidate etiologic agent

por Kistler, Amy L, Gancz, Ady, Clubb, Susan, Skewes-Cox, Peter, Fischer, Kael, Sorber, Katherine, Chiu, Charles Y, Lublin, Avishai, Mechani, Sara, Farnoushi, Yigal, Greninger, Alexander, Wen, Christopher C, Karlene, Scott B, Ganem, Don, DeRisi, Joseph L
Publicado 2008

Differential diagnosis of suspected multiple sclerosis: a consensus approach

por Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH
Publicado 2008

Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes

por Knight, Elysse M., Kim, Soong Ho, Kottwitz, Jessica C., Hatami, Asa, Albay, Ricardo, Suzuki, Akinobu, Lublin, Alex, Alberini, Cristina M., Klein, William L., Szabo, Paul, Relkin, Norman R., Ehrlich, Michelle, Glabe, Charles G., Gandy, Sam, Steele, John W.
Publicado 2016

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

por Kappos, Ludwig, Fox, Robert J., Burcklen, Michel, Freedman, Mark S., Havrdová, Eva K., Hennessy, Brian, Hohlfeld, Reinhard, Lublin, Fred, Montalban, Xavier, Pozzilli, Carlo, Scherz, Tatiana, D'Ambrosio, Daniele, Linscheid, Philippe, Vaclavkova, Andrea, Pirozek-Lawniczek, Magdalena, Kracker, Hilke, Sprenger, Till
Publicado 2021

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

por Havrdová, Eva, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, Hartung, Hans-Peter, Kappos, Ludwig, Lublin, Fred, Selmaj, Krzysztof, Traboulsee, Anthony, Belachew, Shibeshih, Bennett, Iain, Buffels, Regine, Garren, Hideki, Han, Jian, Julian, Laura, Napieralski, Julie, Hauser, Stephen L, Giovannoni, Gavin
Publicado 2018

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

por Polman, Chris H, Reingold, Stephen C, Banwell, Brenda, Clanet, Michel, Cohen, Jeffrey A, Filippi, Massimo, Fujihara, Kazuo, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Lublin, Fred D, Montalban, Xavier, O'Connor, Paul, Sandberg-Wollheim, Magnhild, Thompson, Alan J, Waubant, Emmanuelle, Weinshenker, Brian, Wolinsky, Jerry S
Publicado 2011

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy

por Katz Sand, Ilana, Gnjatic, Sacha, Krammer, Florian, Tuballes, Kevin, Carreño, Juan Manuel, Satyanarayan, Sammita, Filomena, Susan, Staker, Erin, Tcheou, Johnstone, Miller, Aaron, Fabian, Michelle, Safi, Neha, Nichols, Jamie, Patel, Jasmin, Krieger, Stephen, Tankou, Stephanie, Horng, Sam, Klineova, Sylvia, Beck, Erin, Merad, Miriam, Lublin, Fred
Publicado 2023

Polygenicity of Comorbid Depression in Multiple Sclerosis

por Kowalec, Kaarina, Fitzgerald, Kathryn C., Salter, Amber, Dolovich, Casandra, Harder, Arvid, Bernstein, Charles N., Bolton, James, Cutter, Gary R., Graff, Lesley A., Hägg, Sara, Hitchon, Carol A., Lu, Yi, Lublin, Fred, McKay, Kyla A., Patten, Scott B., Patki, Amit, Tiwari, Hemant K., Wolinsky, Jerry S., Marrie, Ruth Ann
Publicado 2023

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study

por Miller, David H., Lublin, Fred D., Sormani, Maria Pia, Kappos, Ludwig, Yaldizli, Özgür, Freedman, Mark S., Cree, Bruce A. C., Weiner, Howard L., Lubetzki, Catherine, Hartung, Hans‐Peter, Montalban, Xavier, Uitdehaag, Bernard M. J., MacManus, David G., Yousry, Tarek A., Gandini Wheeler‐Kingshott, Claudia A. M., Li, Bingbing, Putzki, Norman, Merschhemke, Martin, Häring, Dieter A., Wolinsky, Jerry S.
Publicado 2018

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

por Marignier, Romain, Bennett, Jeffrey L., Kim, Ho Jin, Weinshenker, Brian G., Pittock, Sean J., Wingerchuk, Dean, Fujihara, Kazuko, Paul, Friedemann, Cutter, Gary R., Green, Ari J., Aktas, Orhan, Hartung, Hans-Peter, Lublin, Fred D., Williams, Ian M., Drappa, Jorn, She, Dewei, Cimbora, Daniel, Rees, William, Smith, Michael, Ratchford, John N., Katz, Eliezer, Cree, Bruce A.C.
Publicado 2021

Defining the clinical course of multiple sclerosis: The 2013 revisions

por Lublin, Fred D., Reingold, Stephen C., Cohen, Jeffrey A., Cutter, Gary R., Sørensen, Per Soelberg, Thompson, Alan J., Wolinsky, Jerry S., Balcer, Laura J., Banwell, Brenda, Barkhof, Frederik, Bebo, Bruce, Calabresi, Peter A., Clanet, Michel, Comi, Giancarlo, Fox, Robert J., Freedman, Mark S., Goodman, Andrew D., Inglese, Matilde, Kappos, Ludwig, Kieseier, Bernd C., Lincoln, John A., Lubetzki, Catherine, Miller, Aaron E., Montalban, Xavier, O'Connor, Paul W., Petkau, John, Pozzilli, Carlo, Rudick, Richard A., Sormani, Maria Pia, Stüve, Olaf, Waubant, Emmanuelle, Polman, Chris H.
Publicado 2014

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

por LaRocca, Nicholas G, Hudson, Lynn D, Rudick, Richard, Amtmann, Dagmar, Balcer, Laura, Benedict, Ralph, Bermel, Robert, Chang, Ih, Chiaravalloti, Nancy D, Chin, Peter, Cohen, Jeffrey A, Cutter, Gary R, Davis, Mat D, DeLuca, John, Feys, Peter, Francis, Gordon, Goldman, Myla D, Hartley, Emily, Kapoor, Raj, Lublin, Fred, Lundstrom, Gary, Matthews, Paul M, Mayo, Nancy, Meibach, Richard, Miller, Deborah M, Motl, Robert W, Mowry, Ellen M, Naismith, Rob, Neville, Jon, Panagoulias, Jennifer, Panzara, Michael, Phillips, Glenn, Robbins, Ann, Sidovar, Matthew F, Smith, Kathryn E, Sperling, Bjorn, Uitdehaag, Bernard MJ, Weaver, Jerry
Publicado 2017

Musculoskeletal diseases as the basis for issuing disability certificates for children

por Nieradko-Iwanicka, Barbara, Iwanicki, Janusz Andrzej
Publicado 2023

An Unusual Coexistence of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Endometrioid-Type Endometrial Cancer in a 58-Year-Old Woman: A Case Study with Literature Rev...

por Dłuski, Dominik, Lewkowicz, Dorota, Leszczyńska-Gorzelak, Bożena, Obrzut, Bogdan, Rechberger, Tomasz, Semczuk, Andrzej
Publicado 2018

Warm and dry weather accelerates and elongates Cladosporium spore seasons in Poland

por Kasprzyk, Idalia, Kaszewski, Boguslaw Michal, Weryszko-Chmielewska, Elzbieta, Nowak, Malgorzata, Sulborska, Aneta, Kaczmarek, Joanna, Szymanska, Agata, Haratym, Weronika, Jedryczka, Malgorzata
Publicado 2016